Abiopharma

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

New SEC Form for ResMed Inc.

Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases

Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference

Arcus Biosciences - Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs

Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

Abivax Provides 2026 Corporate Outlook

Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs